Top compounds associated with response to CDRT4


Feature Type Standardized
Nominal ANOVA
mRNA lapatinib UHNBreast pan-cancer AAC -0.49 0.09
mRNA BRD-K01737880 CTRPv2 pan-cancer AAC -0.18 0.2
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC -0.17 0.2
mRNA prima-1 CTRPv2 pan-cancer AAC -0.13 3e-05
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA ABT-199 CTRPv2 pan-cancer AAC -0.13 0.005
mRNA Rapamycin gCSI pan-cancer AAC -0.12 0.05
mRNA Vorinostat gCSI pan-cancer AAC -0.12 0.05
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
Download CSV